Your browser doesn't support javascript.
loading
Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer.
Xu, Jing; Li, Jing-Quan; Chen, Qi-Lei; Shestakova, Elena A; Misyurin, Vsevolod A; Pokrovsky, Vadim S; Tchevkina, Elena M; Chen, Hu-Biao; Song, Hang; Zhang, Jian-Ye.
Afiliação
  • Xu J; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Li JQ; Department of Biochemistry and Molecular Biology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.
  • Chen QL; The First Affiliated Hospital, Hainan Medical University, Haikou, China.
  • Shestakova EA; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
  • Misyurin VA; N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Pokrovsky VS; N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Tchevkina EM; N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Chen HB; Department of Biochemistry, People's Friendship University, Moscow, Russia.
  • Song H; N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Zhang JY; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Front Pharmacol ; 13: 920779, 2022.
Article em En | MEDLINE | ID: mdl-35770088

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China